KYORIN Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
KYORIN Pharmaceutical has a total shareholder equity of ¥130.0B and total debt of ¥20.7B, which brings its debt-to-equity ratio to 15.9%. Its total assets and total liabilities are ¥179.9B and ¥49.9B respectively. KYORIN Pharmaceutical's EBIT is ¥6.4B making its interest coverage ratio -15.7. It has cash and short-term investments of ¥14.5B.
Key information
15.9%
Debt to equity ratio
JP¥20.69b
Debt
| Interest coverage ratio | -15.7x |
| Cash | JP¥14.50b |
| Equity | JP¥130.05b |
| Total liabilities | JP¥49.86b |
| Total assets | JP¥179.91b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4569's short term assets (¥119.9B) exceed its short term liabilities (¥48.4B).
Long Term Liabilities: 4569's short term assets (¥119.9B) exceed its long term liabilities (¥1.5B).
Debt to Equity History and Analysis
Debt Level: 4569's net debt to equity ratio (4.8%) is considered satisfactory.
Reducing Debt: 4569's debt to equity ratio has reduced from 19.4% to 15.9% over the past 5 years.
Debt Coverage: 4569's debt is not well covered by operating cash flow (7.5%).
Interest Coverage: 4569 earns more interest than it pays, so coverage of interest payments is not a concern.